Total Holdings
60
Portfolio diversification across 60 positions
XPH
(NYSEARCA)State Street SPDR S&P Pharmaceuticals ETF
$54.72-- (--)
Loading... - Market loading
XPH ETF Holdings: State Street SPDR S&P Pharmaceuticals ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$313.37M
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
State Street
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Enliven Therapeutics, Inc. | Stock | 2.40% |
| 2 |  | Liquidia Corporation | Stock | 2.39% |
| 3 |  | Corcept Therapeutics Incorporated | Stock | 2.39% |
| 4 |  | MBX | Stock | 2.35% |
| 5 |  | Viatris Inc | Stock | 2.32% |
| 6 |  | Merck & Co., Inc | Stock | 2.31% |
| 7 |  | Axsome Therapeutics, Inc | Stock | 2.28% |
| 8 |  | Amneal Pharmaceuticals, Inc | Stock | 2.27% |
| 9 |  | Phibro Animal Health Corporation | Stock | 2.19% |
| 10 | B BMY | Bristol-Myers Squibb Company | Stock | 2.19% |
| 11 |  | Royalty Pharma plc | Stock | 2.17% |
| 12 |  | Johnson & Johnson | Stock | 2.16% |
| 13 |  | Edgewise Therapeutics Inc | Stock | 2.15% |
| 14 |  | Elanco Animal Health Incorporated | Stock | 2.15% |
| 15 |  | Terns Pharmaceuticals, Inc. | Stock | 2.14% |
| 16 |  | Organon & Co. | Stock | 2.12% |
| 17 |  | Perrigo Company plc | Stock | 2.10% |
| 18 |  | Definium Therapeutics, Inc. | Stock | 2.10% |
| 19 |  | Zoetis Inc | Stock | 2.02% |
| 20 |  | Supernus Pharmaceuticals, Inc | Stock | 2.01% |
| 21 |  | Prestige Consumer Healthcare Inc | Stock | 2.01% |
| 22 |  | Nektar Therapeutics | Stock | 1.99% |
| 23 |  | Pfizer Inc. | Stock | 1.97% |
| 24 |  | Innoviva, Inc | Stock | 1.97% |
| 25 |  | Ligand Pharmaceuticals Incorporated | Stock | 1.96% |
| 26 |  | Eli Lilly and Company | Stock | 1.93% |
| 27 |  | Crinetics Pharmaceuticals, Inc. | Stock | 1.91% |
| 28 |  | Jazz Pharmaceuticals plc | Stock | 1.91% |
| 29 |  | Trevi Therapeutics, Inc. | Stock | 1.90% |
| 30 |  | Tarsus Pharmaceuticals, Inc. | Stock | 1.90% |
| 31 |  | Amylyx Pharmaceuticals, Inc. | Stock | 1.90% |
| 32 |  | Avadel Pharmaceuticals plc | Stock | 1.89% |
| 33 |  | Xeris Biopharma Holdings, Inc. | Stock | 1.89% |
| 34 |  | Pacira BioSciences, Inc. | Stock | 1.88% |
| 35 |  | ANI Pharmaceuticals, Inc | Stock | 1.87% |
| 36 |  | Maze Therapeutics, Inc. Common Stock | Stock | 1.85% |
| 37 |  | Arvinas, Inc | Stock | 1.84% |
| 38 |  | Collegium Pharmaceutical Inc | Stock | 1.81% |
| 39 |  | Amphastar Pharmaceuticals, Inc | Stock | 1.77% |
| 40 |  | Harmony Biosciences Holdings Inc | Stock | 1.74% |
| 41 |  | Harrow Health Inc | Stock | 1.73% |
| 42 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.60% |
| 43 |  | Esperion Therapeutics, Inc | Stock | 1.56% |
| 44 |  | Ventyx Biosciences Inc | Stock | 1.53% |
| 45 |  | Eyepoint Pharmaceuticals Inc | Stock | 1.43% |
| 46 |  | Phathom Pharmaceuticals, Inc | Stock | 1.38% |
| 47 |  | Nuvation Bio Inc | Stock | 1.35% |
| 48 |  | Wave Life Sciences Ltd | Stock | 1.18% |
| 49 |  | Ocular Therapeutix Inc | Stock | 1.09% |
| 50 | K KMPH | KemPharm Inc | Stock | 1.07% |
Frequently Asked Questions About State Street SPDR S&P Pharmaceuticals ETF Holdings
What are the top holdings in XPH?
State Street SPDR S&P Pharmaceuticals ETF (XPH) holds 60 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is XPH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review XPH's holdings table to analyze concentration risk.
What is XPH's sector allocation?
The Sector Allocation chart shows how XPH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does XPH invest in?
XPH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is XPH ETF?
XPH's diversification can be assessed by reviewing its 60 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.